NCT06264414: Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
- State
- Not started
- Phase
- Phase 3
- People
- 262 planned
- Started
- Feb 2025
- Primary completion
- Jun 2026
- Arms
- DTT106
- Results
- None posted
- 20 Feb 2024: Trial registered